Published in World Health Stat Q on January 01, 1992
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45
Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun (1998) 1.31
Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways. Biochem J (2004) 1.21
The impact of climate change on the geographical distribution of two vectors of Chagas disease: implications for the force of infection. Philos Trans R Soc Lond B Biol Sci (2015) 1.12
Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides. J Clin Microbiol (2001) 1.09
Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. J Clin Microbiol (1994) 1.08
Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest (1998) 1.01
Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Clin Diagn Lab Immunol (2003) 0.96
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. Infect Immun (1997) 0.87
Progress towards the elimination of transmission of Chagas disease in Latin America. World Health Stat Q (1997) 0.89